Additionally, the EGM agreed on the amendment of Articles 3, 4, 6, and 7 of the company’s Articles of Association
A trader works at the Egyptian stock market in Cairo .
REUTERS/Mohamed Abd El Ghany
By Staff Writer, Arab Finance
Egypt - The extraordinary general meeting (EGM) of Ibnsina Pharma (ISPH) approved to increase the company’s issued capital to EGP 280 million from EGP 280 million through the issuance of bonus shares, according to a statement filed to the Egyptian Exchange (EGX).
Additionally, the EGM agreed on the amendment of Articles 3, 4, 6, and 7 of the company’s Articles of Association.
Ibnsina is an Egypt-based pharmaceutical distribution company. The company distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW